Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.28 EUR -3.45% Market Closed
Market Cap: 18.2m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Operating Margin
Biotechnology Assets SA

-43.2%
Current
-1%
Average
-7.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-43.2%
=
Operating Profit
-1.3m
/
Revenue
3.1m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
ES
Biotechnology Assets SA
MAD:BST
17.8m EUR
-43%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
314.9B USD
28%
US
Amgen Inc
NASDAQ:AMGN
140.6B USD
19%
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD
40%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
135.7B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
36B EUR
-22%
Country ES
Market Cap 17.8m EUR
Operating Margin
-43%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 314.9B USD
Operating Margin
28%
Country US
Market Cap 140.6B USD
Operating Margin
19%
Country US
Market Cap 115.7B USD
Operating Margin
38%
Country US
Market Cap 103.9B USD
Operating Margin
40%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 135.7B AUD
Operating Margin
26%
Country US
Market Cap 77.8B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 36B EUR
Operating Margin
-22%
No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
17.8m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
0.29 EUR
Undervaluation 2%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-43.2%
=
Operating Profit
-1.3m
/
Revenue
3.1m
What is the Operating Margin of Biotechnology Assets SA?

Based on Biotechnology Assets SA's most recent financial statements, the company has Operating Margin of -43.2%.